By Lívia Honório de Figueiredo

August 9, 2017

Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes

Valid since August 10 2017 – date of its publication on the Official Federal Gazette – this new rule confirms all the principals and procedures already stated on Normative Instruction Nº 01, from May 31 2017.

In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com

Back

Last by Lívia Honório de Figueiredo

September 9, 2024

Kasznar Leonardos wins LMG Life Sciences

We are honored to announce that Kasznar Leonardos has won the Firm of the Year: Brazil award at the LMG Life Sciences! … Kasznar Leonardos wins LMG Life Sciences

May 4, 2023

Kasznar Leonardos attends the BIO International Convention

Our specialists Lívia Figueiredo and Jansen Viana are set to attend the BIO International Convention, which will take place from June 5-8, 2023, … Kasznar Leonardos attends the BIO International Convention

April 24, 2023

“Brazil: The patent combination conundrum” for LSIPR Magazine

Patents to new medicines usually protect the active ingredient (compound), provided that it is new and inventive. It is also a common … “Brazil: The patent combination conundrum” for LSIPR Magazine